Day: December 7, 2020

SAN JOSE, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — California Water Service Group (Group) (NYSE: CWT) today announced the promotion of Michael B. Luu to Vice President, Information Technology and Chief Risk Officer, effective January 1, 2021. In this role, Luu will oversee the information technology, cyber security, safety, security, and emergency preparedness functions within Group and its subsidiaries.Luu currently serves as Vice President, Customer Service and Chief Information Officer, a position he has held since January 2017. Prior to his current position, Luu held various roles within the company, including Vice President, Customer Service and Information Technology; Acting District Manager of subsidiary California Water Service’s Los Altos District; Director of Information Technology; and CIS Development Manager. He has...

SHENZHEN, China, Dec. 07, 2020 (GLOBE NEWSWIRE) — Meten EdtechX Education Group Ltd. (Nasdaq: METX) (“Meten EdtechX” or the “Company”), a leading omnichannel English language training (“ELT”) service provider in China, today announced the filing of a Tender Offer and Prospectus Supplements (the “Offer”) with the U.S. Securities and Exchange Commission (the “SEC”) pursuant to which the exercise price of each tendered warrant of the Company (the “Warrant”) is being reduced to $1.40 per share.To participate in the Offer and exercise Warrants at the reduced exercise price, holders will be required to tender such Warrants prior to 11:59 p.m. (Eastern Time) on January 5, 2021, as the same may be extended by the Company in its sole discretion (the “Expiration Date”).There is a sixty-five percent (65%) minimum participation requirement...

– Treatment with Mitapivat Induced Hemoglobin Increase of ≥1.0 g/dL in 6 of 11 (55%) Efficacy Evaluable Patients, Decreased Markers of Hemolysis, Reduced 2,3-DPG and Increased ATP –– Safety Profile Generally Consistent with Previously Presented Data in Patients with Pyruvate Kinase Deficiency and Thalassemia –– Data Support Advancement of Mitapivat to Pivotal Development in Sickle Cell Disease; Company Expects to Initiate Pivotal Program in 2021 –– Company to Host Investor Event and Webcast Tomorrow, December 8, at 8:00 a.m. ET –CAMBRIDGE, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today reported updated data from a Phase 1 trial of mitapivat, the company’s first-in-class pyruvate kinase R (PKR) activator,...

NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) — Japan Smaller Capitalization Fund, Inc. (NYSE: JOF) (the “Fund”) announced that it would make an ordinary income distribution of $0.1281 per share and a long-term capital gains distribution of $0.2160 per share, payable on December 28, 2020 to shareholders of record on December 18, 2020. The ex-dividend date will be December 17, 2020.The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the entirety of its fiscal year and may be subject to changes based on tax regulations. The Fund intends to send a Form 1099-DIV for the calendar year concerning the tax treatment...

MONROE TOWNSHIP, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (“OPT” or “the Company”) (Nasdaq: OPTT), a leader in innovative and cost-effective ocean energy solutions, today announced financial results for the second quarter of fiscal year 2021 ended October 31, 2020.Recent Operational HighlightsSigned contract with Adams Communications & Engineering Technology (ACET) to evaluate a PB3 PowerBuoy® solution to support the U.S. Navy’s Naval Postgraduate School’s Sea, Land, Air, Military Research (SLAMR) Initiative.Received DeepStar® project award to study deployment and operational requirements of utilizing OPT’s PB3 PowerBuoy® to provide remotely controllable zero carbon power for deepwater subsea oil production applications.Deployed the OPT Marine Surveillance...

BASKING RIDGE, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that management is scheduled to present at the 13th Annual LD Micro Main Event Conference.Presentation details:Date: Monday, December 14, 2020Time: 2:40-3:00pm EDTInvestors can register for the conference HERE.Following the conference a webcast replay of the presentation will be available on the Investor section of the company’s website, www.electrocore.com.About electroCore, Inc.electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative...

TORONTO, Dec. 07, 2020 (GLOBE NEWSWIRE) — Financial 15 Split Corp. (“Financial 15”) is pleased to announce it has reinstated Class A share dividends at a monthly distribution rate of $0.1257 for each post-consolidation FTN Class A share ($1.5084 annually) and declares $0.05625 for each FTN.PR.A Preferred share ($0.675 annually). The current rate for the Class A shares of $1.5084 is a post-consolidation yield of 17% based on Friday’s pre-consolidation closing price of $3.65. This is an increase in the dividend for the Class A shares from previous guidance. Distributions are payable January 8, 2021 to shareholders on record as at December 31, 2020.Since inception Class A shareholders have received a total of $20.53 per share and Preferred shareholders have received a total of $9.08 per share inclusive of this distribution,...